By Counterforce Health Team in Gilenya (fingolimod) —

How to Get Gilenya (Fingolimod) Covered by Blue Cross Blue Shield in Virginia: Complete PA Guide with Forms and Appeals

Answer Box: Fast Track to Gilenya Coverage in Virginia

Getting Gilenya (fingolimod) covered by Blue Cross Blue Shield in Virginia requires prior authorization in most cases. Your fastest path: 1) Verify your plan's formulary status through Anthem's provider portal, 2) Have your neurologist submit a complete PA request with baseline testing documentation, and 3) If denied, file an internal appeal within 180 days. Virginia offers external review through the State Corporation Commission Bureau of Insurance with Form 216-A if internal appeals fail.

Start today: Call the member services number on your insurance card to confirm Gilenya's formulary tier and PA requirements for your specific plan.

Table of Contents

Verify Your Plan Coverage

Before starting the prior authorization process, confirm your specific Blue Cross Blue Shield plan's requirements. In Virginia, you're likely covered by Anthem Blue Cross Blue Shield, which maintains the largest market share at approximately 43%.

Coverage Quick Check

  1. Log into your member portal or call 1-800-810-2583 (24/7 member services)
  2. Request your current formulary - Gilenya may be on Tier 3 or 4 (specialty tier)
  3. Ask specifically about fingolimod PA requirements - criteria change regularly with updates effective February 1, July 1, and December 1 annually
Note: Anthem regularly updates prior authorization requirements. Recent changes were effective December 1, 2024, and February 1, 2025, so verify current status.

Required Forms and Documentation

Core Prior Authorization Package

Your neurologist will need to submit a comprehensive package through Anthem's clinical review process:

Essential Documentation:

  • Complete diagnostic workup confirming relapsing MS diagnosis with ICD-10 codes
  • Baseline cardiac assessment including EKG (required due to bradycardia risk)
  • Ophthalmologic examination (macular edema monitoring)
  • Current vaccination status and infection screening
  • Documentation of contraindicated medications review

Clinical Justification Must Include:

  • Prior therapy trials and specific reasons for discontinuation or failure
  • Current disability status and treatment goals
  • Dosing rationale based on patient weight and clinical factors
  • Monitoring plan for first-dose observation and ongoing safety
Clinician Corner: Medical necessity letters should reference FDA labeling for fingolimod's approved indication in relapsing MS and include specific citations from American Academy of Neurology guidelines or National Multiple Sclerosis Society treatment recommendations.

Step Therapy Documentation

If your plan requires step therapy, document:

  • First-line failures: Injectable interferons or glatiramer acetate with specific adverse events or lack of efficacy
  • Contraindications: Any medical reasons why standard first-line therapies aren't appropriate
  • Prior authorization history: Previous approvals for other MS medications

Submission Portals and Methods

Primary Submission Route: Anthem Provider Portal

Fastest processing: Submit through Anthem's provider portal rather than fax for expedited review.

Portal Benefits:

  • Real-time status tracking
  • Faster processing (15 business days vs. longer fax processing)
  • Secure document upload capability
  • Automated confirmation receipts

Alternative Submission Methods

Fax Submissions: Contact Anthem member services for current fax numbers (verify with source linked above)

Phone Support for Providers: 1-800-901-0020 for HealthKeepers Plus case management referrals

Tip: Incomplete submissions are the leading cause of approval delays. Include all required documentation in your initial request to prevent back-and-forth communication.

Common Denial Reasons and Solutions

Denial Reason Solution Strategy Required Documentation
Missing baseline testing Submit complete cardiac and ophthalmologic evaluations EKG, ophthalmology report, vital signs
Inadequate step therapy Document specific failures or contraindications to first-line agents Prior therapy records, adverse event documentation
Quantity limits exceeded Justify dosing based on clinical factors Weight-based calculations, specialist rationale
"Not medically necessary" Strengthen clinical narrative with guideline support AAN guidelines, peer-reviewed studies

Medical Necessity Letter Checklist

Your neurologist's letter should address:

  • Specific MS subtype and current disease activity
  • Failed therapies with dates, duration, and reasons for discontinuation
  • Clinical rationale for fingolimod over alternatives
  • Monitoring plan including first-dose observation protocols
  • Treatment goals with measurable outcomes

Appeals Process for Virginia

Internal Appeals (First Level)

Timeline: File within 180 days of initial denial for commercial plans

Required Documents:

  • Original denial letter
  • Additional clinical documentation
  • Updated medical necessity letter
  • Any new supporting evidence

Processing Time: 30 days for standard appeals, 72 hours for expedited reviews

External Review Through Virginia Bureau of Insurance

If internal appeals fail, Virginia offers independent external review through the State Corporation Commission Bureau of Insurance.

Eligibility: Available after completing internal appeals process

Timeline: File Form 216-A within 120 days of final internal denial

Required Documents:

  • Form 216-A (External Review Request)
  • Final denial letter from Anthem
  • Medical records release form
  • Copy of insurance card
  • Any additional supporting documentation

Processing: 45 days for standard review, 72 hours for expedited medical necessity cases

Contact: Virginia Bureau of Insurance Consumer Services at 1-877-310-6560

Virginia Advantage: The state offers expedited external review for certain conditions without exhausting internal appeals, and the process is free to consumers.

Specialty Pharmacy Coordination

Once approved, Gilenya typically routes through Anthem's contracted specialty pharmacy network.

Enrollment Process

Primary Specialty Pharmacies:

  • Accredo Specialty Pharmacy
  • CVS Specialty Pharmacy

Coordination Steps:

  1. Contact within 48 hours of PA approval
  2. Complete enrollment including insurance verification
  3. Schedule delivery with temperature-controlled shipping
  4. Arrange first-dose monitoring at certified facility

First-Dose Monitoring Requirements

Gilenya requires 6-hour cardiac monitoring after the first dose due to bradycardia risk. Coordinate with:

  • Certified infusion centers
  • Neurologist's office with appropriate monitoring equipment
  • Hospital outpatient departments

Support and Contact Information

Patient Support Numbers

Anthem Member Services: 1-800-810-2583 (24/7) Collect Call Option: 1-804-673-1177

Provider Support

Case Management: 1-800-901-0020 (TTY: 711) Prior Authorization Support: Available through Availity portal

Virginia State Resources

Bureau of Insurance External Review: 1-877-310-6560 Managed Care Ombudsman: Same number as above for HMO issues

Cost Assistance Programs

Manufacturer Support

Novartis Patient Assistance: Offers copay cards and financial assistance for eligible patients Eligibility: Typically available for commercially insured patients with coverage gaps

State and Federal Programs

Virginia Medicaid: Covers Gilenya with prior authorization for eligible recipients Medicare Part D: Coverage varies by plan; check formulary tier and coverage gap implications

Frequently Asked Questions

How long does Anthem PA approval take in Virginia? Standard processing is 15 business days through the provider portal. Expedited reviews for urgent medical needs can be completed within 72 hours.

What if Gilenya is non-formulary on my plan? Request a formulary exception with medical necessity documentation. Your neurologist can appeal based on clinical superiority over formulary alternatives.

Can I request an expedited appeal if my MS is worsening? Yes, Virginia allows expedited external review for urgent medical situations. Your neurologist must certify that delays would seriously jeopardize your health.

Does step therapy apply if I've tried therapies outside Virginia? Documentation from any licensed provider should count toward step therapy requirements. Ensure complete records transfer to your Virginia neurologist.

What happens if external review denies coverage? The IRO decision is final and binding. Consider consulting with a healthcare attorney if you suspect a violation of state insurance law or your plan documents.

Counterforce Health helps patients and clinicians navigate complex prior authorization processes by analyzing denial letters and plan policies to create targeted, evidence-backed appeals. Their platform identifies specific denial reasons and drafts point-by-point rebuttals aligned with each payer's requirements, potentially saving weeks in the approval process.

For additional support with your Gilenya prior authorization or appeal, visit Counterforce Health to learn how their specialized platform can help strengthen your case with payer-specific documentation and evidence.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on your specific plan documents and clinical circumstances. Always consult with your healthcare provider and insurance company for guidance specific to your situation. For complex appeals, consider consulting with a healthcare attorney or patient advocacy organization.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.